MELINDA NIEMAN: Open Payments
NPI 1861595050 · HAMILTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 63 payments from 10 companies in 2025. Trend: 2023 $518 · 2024 $628 · 2025 $961
Food & beverage: $961
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $209 |
| Teva Pharmaceuticals USA, Inc. | 13 | $185 |
| Lundbeck LLC | 10 | $154 |
| Janssen Pharmaceuticals, Inc | 6 | $113 |
| Vanda Pharmaceuticals Inc. | 4 | $89 |
| Alkermes, Inc. | 4 | $76 |
| E.R. Squibb & Sons, L.L.C. | 4 | $57 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| ABBVIE INC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: CAPLYTA, UZEDY, INVEGA SUSTENNA, ABILIFY MAINTENA, HETLIOZ, ARISTADA, REXULTI, COBENFY.
Industry payments across OH — which companies pay providers there.
